Clinical Trial Update: A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 three-period crossover trial evaluating GSK573719 as monotherapy in adults with asthma has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK573719

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-20